NCT02406118

Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TME

Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal Total Mesorectal Excision

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 49 (estimated)
• Sponsor: National Cancer Center, Korea · Other Government
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is evaluation of the safety and the efficacy of transanal total mesorectal excision.

Detailed description

Subjects will have their rectal cancer removed using a technique combining surgery through the anus and standard laparoscopy. Transanal visualization will be using endoscopy. At the end of the procedure, the rectum will be removed though the anus or ileostomy formation site, the bowel will be re-connected to the anus, and a temporary diverting stoma will be created, which is standard of care following surgery for this type of cancer.

Conditions

• Rectal Cancer

Interventions

Type	Name	Description
PROCEDURE	Transanal total mesorectal excision	Subjects will have their rectal cancer removed using a technique combining surgery through the anus and standard laparoscopy. Transanal visualization will be using endoscopy. At the end of the procedure, the rectum will be removed though the anus or ileostomy formation site, the bowel will be re-connected to the anus, and a temporary diverting stoma will be created, which is standard of care following surgery for this type of cancer.

Timeline

• Start date: 2015-03-01
• Primary completion: 2018-12-01
• Completion: 2022-12-01
• First posted: 2015-04-02
• Last updated: 2021-09-10

Locations

1 site across 1 country: South Korea